Identification of Driver Genes and miRNAs in Ovarian Cancer through an Integrated In-Silico Approach

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ovarian cancer is a leading cause of death among gynecological malignancies.
• MicroRNAs (miRNAs) are increasingly recognized for their role in ovarian cancer development and progression.

Purpose of the Study:

• To identify specific miRNAs and their associated genes crucial for the early prognosis of ovarian cancer.
• To analyze differentially expressed genes (DEGs) and microRNAs in ovarian cancer samples compared to healthy controls.

Main Methods:

• Utilized the microarray dataset GSE119055 from the NCBI GEO database.
• Performed differential expression miRNA (DEM) analysis using R software and Bioconductor packages.
• Identified hub genes associated with both upregulated and downregulated miRNA networks.

Main Results:

• Identified five top upregulated miRNAs (hsa-miR-130b-3p, hsa-miR-18a-5p, hsa-miR-182-5p, hsa-miR-187-3p, hsa-miR-378a-3p) and five top downregulated miRNAs (hsa-miR-501-3p, hsa-miR-4324, hsa-miR-500a-3p, hsa-miR-1271-5p, hsa-miR-660-5p).
• Identified seven hub genes (SCN2A, BCL2, MAF, ZNF532, CADM1, ELAVL2, ESRRG) for the downregulated miRNA network.
• Identified two hub genes (PRKACB, TAOK1) for the upregulated miRNA network.

Conclusions:

• The identified miRNAs and hub genes represent potential biomarkers for early ovarian cancer prognosis.
• Further research into these molecular players could lead to improved diagnostic and therapeutic strategies for ovarian cancer.